Publication: Magyar Közlöny
Issue: MK-2007-56 (Year: 2007, Number: 56)
Era: 2004-2010
Section: 
Paragraph Index: 75

3. Other anti-estrogenic substances including, but not limited to, clomiphene, cyclofenil, fulvestrant. S5. DIURETICS AND OTHER MASKING AGENTS Diuretics and other masking agents are prohibited. Masking agents include but are not limited to: di u re tics*, epi tes tos te ro ne, pro be ne cid, alp hareductase in hi bi tors (e.g. fi nas te ri de, du tas te ri de), plas ma ex pan ders (e.g. al bu min, dext ran, hyd ro xy et hyl starch). Diuretics include: ace ta zo la mi de, ami lo ri de, bu me ta ni de, can re no ne, chlor ta li do ne, etac ry nic acid, fu ro se mi de, in da pa mi de, me to la zo ne, spi ro no lac to ne, thi a zi des (e.g. bend rof lu - met hi a zi de, chlo rot hi a zi de, hyd roch lo rot hi a zi de), tri - am te re ne and ot her subs tan ces with a similar chemical structure or similar biological effect(s). * A The ra pe u tic Use Exemp ti on is not va lid if an Ath le te’s uri ne con ta ins a di u re tic in as so ci a ti on with thres hold or sub-thres hold le vels of a Pro hi bi - ted Subs tan ce(s). PROHIBITED METHODS M1. ENHANCEMENT OF OXYGEN TRANSFER The following are prohibited. (a) Blood doping, including the use of autologous, homologous or heterologous blood or red blood cell products of any origin, other than for medical treatment. (b) Artificially enhancing the uptake, transport or delivery of oxygen, including but not limited to 2007/56. szám perfluorochemicals, efaproxiral (RSR13) and modified haemoglobin products (e.g. haemoglobin-based blood substitutes, microencapsulated haemoglobin products). M2. CHEMICAL AND PHYSICAL MANIPULA - TION The following is prohibited: Tampering, or attempting to tamper, in order to alter the integrity and validity of Samples collected in Doping Controls. These include but are not limited to intravenous infusions*, catheterization, and urine substitution. * Ex cept as a le gi ti ma te acu te me di cal tre at ment, int ra ve no us in fu si ons are pro hi bi ted. M3. GENE DOPING The non-therapeutic use of cells, genes, genetic elements, or of the modulation of gene expression, having the capacity to enhance athletic performance, is prohibited. SUBSTANCES AND METHODS PROHIBITED IN-COMPETITION In addition to the categories S1 to S5 and M1 to M3 defined above, the following categories are prohibited in competition: PROHIBITED SUBSTANCES S6. STIMULANTS The following stimulants are prohibited, including both their optical (D- and L-) isomers where relevant: ad ra fi nil, am fep ra mo ne, amip he na zo le, amp he ta mi - ne, amp he ta mi nil, benzp he ta mi ne, bro man tan, car - phedon, cat hi ne*, clo ben zo rex, co ca i ne, dimethylam - phetamine, ep hed ri ne**, eti lamp he ta mi ne, eti lef ri ne, famp ro fa zo ne, fen cam fa min, fen ca mi ne, fe netyl li ne, fenf lu ra mi ne, fenp ro po rex, fur fe no rex, me fe no rex, mep hen ter mi ne, me so carb, met hamp he ta mi ne, met hy - lamp he ta mi ne, met hy le ne di o xy amp he ta mi ne, met hy - le ne di o xy-met hamp he ta mi ne, met hy lep hed ri ne**, met hylp he ni da te, mo da fi nil, ni ket ha mi de, norfenflu - ramine, parahydroxyamphetamine, pemo line, phen dimet ra zi ne, phenmetrazine, phentermine, prolintane, selegiline, strychnine and other substances with a similar chemical structure or similar biological effect(s)***. * Cat hi ne is pro hi bi ted when its con cent ra ti on in uri ne is gre a ter than 5 mic rog rams per mil li li ter. ** Each of ep hed ri ne and met hy lep hed ri ne is pro hi bi ted when its con - cent ra ti on in uri ne is gre a ter than 10 mic rog rams per mil li li ter. *** The subs tan ces inc lu ded in the 2005 Mo ni tor ing Pro gram me (bup ro - pi on, caf fe i ne, pheny leph ri ne, phenylp ro pa no la mi ne, pip rad rol, pseudoe - phedrine, sy neph ri ne) are not con si de red as Pro hi bi ted Subs tan ces. NOTE: Adrenaline associated with local anaesthetic agents or by local administration (e.g. nasal, ophthalmologic) is not prohibited. S7. NARCOTICS The following narcotics are prohibited: buprenorphine, dextromoramide, diamorphine (heroin), fentanyl and its derivatives, hydromorphone, methadone, morphine, oxycodone, oxymorphone, pentazocine, pethidine. S8. CANNABINOIDS Cannabinoids (e.g. hashish, marijuana) are prohibited. S9. GLUCOCORTICOSTEROIDS All glucocorticosteroids are prohibited when administered orally, rectally, intravenously or intramuscularly. Their use requires a Therapeutic Use Exemption approval. All other routes of administration require an abbreviated Therapeutic Use Exemption. Dermatological preparations are not prohibited. SUBSTANCES PROHIBITED IN PARTICULAR SPORTS P1. ALCOHOL Alcohol (ethanol) is prohibited in-competition only, in the following sports. Detection will be conducted by analysis of breath and/or blood. The doping violation threshold for each Federation is reported in parenthesis. Aeronautic (FAI) (0.20 g/L) Archery (FITA) (0.10 g/L) Automobile (FIA) (0.10 g/L) Billiards (WCBS) (0.20 g/L) Boules (CMSB) (0.10 g/L) Karate (WKF) (0.10 g/L) Modern Pentathlon (UIPM) (0.10 g/L) for disciplines involving shooting Motorcycling (FIM) (0.00 g/L) Skiing (FIS) (0.10 g/L) P2. BETA-BLOCKERS Unless otherwise specified, beta-blockers are prohibited in-competition only, in the following sports. Aeronautic (FAI) Archery (FITA) (also prohibited out-of-competition) Automobile (FIA) Billiards (WCBS) Bobsleigh (FIBT) Boules (CMSB) Bridge (FMB) Chess (FIDE) Curling (WCF) Gymnastics (FIG) 2007/56. szám Motorcycling (FIM) Modern Pentathlon (UIPM) for disciplines involving shooting Nine-pin bowling (FIQ) Sailing (ISAF) for match race helms only Shooting (ISSF) (also prohibited out-of-competition) Skiing (FIS) in ski jumping and free style snow board Swimming (FINA) in diving and synchronized swimming Wrestling(FILA) Beta-blockers include, but are not limited to, the following: ace bu to lol, alp re no lol, ate no lol, be ta xo lol, bi sop ro - lol, bu no lol, car te o lol, car ve di lol, ce lip ro lol, es mo lol, la be ta lol, le vo bu no lol, me tip ra no lol, me top ro lol, na do - lol, oxp re no lol, pin do lol, prop ra no lol, so ta lol, timolol. SPECIFIED SUBSTANCES* „Specified Substances”* are listed below: ep hed ri ne, L-met hy lamp he ta mi ne, methylephed - rine; cannabinoids; all inhaled Beta-2 Agonists, except clenbuterol; probenecid; all Glucocorticosteroids; all Beta Blockers; alcohol. * „The Pro hi bi ted List may iden ti fy spe ci fi ed subs tan ces which are par ti - cu larly sus cep tib le to unin ten ti o nal an ti-do ping rule vi o lat ions be ca u se of the ir ge ne ral ava i la bi lity in me di ci nal pro ducts or which are less li kely to be suc cess fully abu sed as do ping agents.” A do ping vi o lat ion in vol ving such subs tan ces may re sult in a re du ced sanc ti on pro vi ded that the „… Ath le te can es tab lish that the Use of such a spe ci fi ed subs tan ce was not in ten ded to en - han ce sport per for man ce …” ANNEX II STANDARDS FOR GRANTING THERAPEUTIC USE EXEMPTIONS Extract from „INTERNATIONAL STANDARD FOR THERAPEUTIC USE EXEMPTIONS” of the World Anti-Doping Agency (WADA); in force 1 January 2005 4.0 Criteria for granting a therapeutic use exemption A Therapeutic Use Exemption (TUE) may be granted to an Athlete permitting the use of a Prohibited Substance or Prohibited Method contained in the Prohibited List. An application for a TUE will be reviewed by a Therapeutic Use Exemption Committee (TUEC). The TUEC will be appointed by an Anti-Doping Organization. An exemption will be granted only in strict accordance with the following criteria: [Comment: This standard applies to all Athletes as defined by and subject to the Code i.e. able-bodied athletes and athletes with disabilities. This Standard will be applied according to an individual’s circumstances. For example, an exemption that is appropriate for an athlete with a disability may be inappropriate for other athletes.] 4.1 The Athlete should submit an application for a TUE no less than 21 days before participating in an Event. 4.2 The Athlete would experience a significant impairment to health if the Prohibited Substance or Prohibited Method were to be withheld in the course of treating an acute or chronic medical condition. 4.3 The therapeutic use of the Prohibited Substance or Prohibited Method would produce no additional enhancement of performance other than that which might be anticipated by a return to a state of normal health following the treatment of a legitimate medical condition. The use of any Prohibited Substance or Prohibited Method to increase „lownormal” levels of any endogenous hormone is not considered an acceptable therapeutic intervention. 4.4 There is no reasonable therapeutic alternative to the use of the otherwise Prohibited Substance or Prohibited Method. 4.5 The necessity for the use of the otherwise Prohibited Substance or Prohibited Method cannot be a consequence, wholly or in part, of prior non-therapeutic use of any substance from the Prohibited List. 4.6 The TUE will be cancelled by the granting body, if (a) the Athlete does not promptly comply with any requirements or conditions imposed by the Anti-Doping Organization granting the exemption; (b) the term for which the TUE was granted has expired; (c) the Athlete is advised that the TUE has been withdrawn by the Anti-Doping Organization. [Comment: Each TUE will have a specified duration as decided upon by the TUEC. There may be cases when a TUE has expired or has been withdrawn and the Prohibited Substance subject to the TUE is still present in the Athlete’s body. In such cases, the Anti-Doping Organization conducting the initial review of an adverse finding will consider whether the finding is consistent with expiry or withdrawal of the TUE.] 4.7 An application for a TUE will not be considered for retroactive approval except in cases where: (a) emergency treatment or treatment of an acute medical condition was necessary; or (b) due to exceptional circumstances, there was insufficient time or opportunity for an applicant to submit, or a TUEC to consider, an application prior to Doping Control. 2007/56. szám [Comment: Medical Emergencies or acute medical situations requiring administration of an otherwise Prohibited Substance or Prohibited Method before an application for a TUE can be made, are uncommon. Similarly, circumstances requiring expedited consideration of an application for a TUE due to imminent competition are infrequent. Anti-Doping Organizations granting TUEs should have internal procedures which permit such situations to be addressed.] 5.0. Confidentiality of information 5.1 The applicant must provide written consent for the transmission of all information pertaining to the application to members of the TUEC and, as required, other independent medical or scientific experts, or to all necessary staff involved in the management, review or appeal of TUEs. Should the assistance of external, independent experts be required, all details of the application will be circulated without identifying the Athlete involved in the Athlete’s care. The applicant must also provide written consent for the decisions of the TUEC to be distributed to other relevant Anti-Doping Organizations under the provisions of the Code. 5.2 The members of the TUECs and the administration of the Anti-Doping Organization involved will conduct all of their activities in strict confidence. All members of a TUEC and all staff involved will sign confidentiality agreements. In particular they will keep the following information confidential: (a) all medical information and data provided by the Athlete and physician(s) involved in the Athlete’s care; (b) all details of the application including the name of the physician(s) involved in the process. Should the Athlete wish to revoke the right of the TUEC or the WADA TUEC to obtain any health information on his/her behalf, the Athlete must notify his/her medical practitioner in writing of the fact. As a consequence of such a decision, the Athlete will not receive approval for a TUE or renewal of an existing TUE. 6.0 Therapeutic use exemption committees (TUECs) TUECs shall be constituted and act in accordance with the following guidelines: 6.1 TUECs should include at least three physicians with experience in the care and treatment of Athletes and a sound knowledge of clinical, sports and exercise medicine. In order to ensure a level of independence of decisions, a majority of the members of the TUEC should not have any official responsibility in the Anti-Doping Organization. All members of a TUEC will sign a conflict of interest agreement. In applications involving Athletes with disabilities, at least one TUEC member must possess specific experience with the care and treatment of Athletes with disabilities. 6.2 TUECs may seek whatever medical or scientific expertise they deem appropriate in reviewing the circumstances of any application for a TUE. 6.3 The WADA TUEC shall be composed following the criteria set out in Article 6.1. The WADA TUEC is established to review on its own initiative TUE decisions granted by Anti-Doping Organizations. As specified in Article 4.4 of the Code, the WADA TUEC, upon request by Athletes who have been denied TUEs by an Anti-Doping Organization will review such decisions with the power to reverse them. 7.0 Therapeutic use exemption (TUE) application process 7.1 A TUE will only be considered following the receipt of a completed application form that must include all relevant documents (see Appendix 1 – TUE form). The application process must be dealt with in accordance with the principles of strict medical confidentiality. 7.2 The TUE application form(s), as set out in Appendix 1, can be modified by Anti-Doping Organizations to include additional requests for information, but no sections or items shall be removed. 7.3 The TUE application form(s) may be translated into other language(s) by Anti-Doping Organizations, but English or French must remain on the application form(s). 7.4 An Athlete may not apply to more than one Anti-Doping Organization for a TUE. The application must identify the Athlete’s sport and, where appropriate, discipline and specific position or role. 7.5 The application must list any previous and/or current requests for permission to use an otherwise Prohibited Substance or Prohibited Method, the body to whom that request was made, and the decision of that body. 7.6 The application must include a comprehensive medical history and the results of all examinations, laboratory investigations and imaging studies relevant to the application. 7.7 Any additional relevant investigations, examinations or imaging studies requested by the TUEC of the Anti-Doping Organization will be undertaken at the expense of the applicant or his/her national sport governing body. 7.8 The application must include a statement by an appropriately qualified physician attesting to the necessity of the otherwise Prohibited Substance or Prohibited Method in the treatment of the Athlete and describing why 2007/56. szám an alternative, permitted medication cannot, or could not, be used in the treatment of this condition. 7.9 The dose, frequency, route and duration of administration of the otherwise Prohibited Substance or Prohibited Method in question must be specified. 7.10 Decisions of the TUEC, should be completed within 30 days of receipt of all relevant documentation and will be conveyed in writing to the Athlete by the relevant Anti-Doping Organization. Where a TUE has been granted to an Athlete in the Anti-Doping Organization Registered Testing Pool, the Athlete and WADA will be provided promptly with an approval which includes information pertaining to the duration of the exemption and any conditions associated with the TUE. 7.11 (a) Upon receiving a request by an Athlete for review, as specified in Article 4.4 of the Code, the WADA TUEC will, as specified in Article 4.4 of the Code, be able to reverse a decision on a TUE granted by an Anti-Doping Organization. The Athlete shall provide to the WADA TUEC all the information for a TUE as submitted initially to the Anti-Doping Organization accompanied by an application fee. Until the review process has been completed, the original decision remains in effect. The process should not take longer than 30 days following receipt of the information by WADA. (b) WADA can undertake a review at any time. The WADA TUEC will complete its review within 30 days. 7.12 If the decision regarding the granting of a TUE is reversed on review, the reversal shall not apply retroactively and shall not disqualify the Athlete’s results during the period that the TUE had been granted and shall take effect no later than 14 days following notification of the decision to the Athlete. 8.0 Abbreviated therapeutic use exemption (ATUE) application process 8.1 It is acknowledged that some substances included on the List of Prohibited Substances are used to treat medical conditions frequently encountered in the Athlete population. In such cases, a full application as detailed in section 4 and section 7 is unnecessary. Accordingly an abbreviated process of the TUE is established. 8.2 The Prohibited Substances or Prohibited Methods which may be permitted by this abbreviated process are strictly limited to the following: Beta-2 agonists (formoterol, salbutamol, salmeterol and terbutaline) by inhalation, and glucocorticosteroids by non-systemic routes. 8.3 To use one of the substances above, the Athlete shall provide to the Anti-Doping Organization a medical notification justifying the therapeutic necessity. Such medical notification, as contained in Appendix 2, shall describe the diagnosis, name of the drug, dosage, route of administration and duration of the treatment. When applicable any tests undertaken in order to establish the diagnosis should be included (without the actual results or details). 8.4 The abbreviated process includes: (a) approval for use of Prohibited Substances subject to the abbreviated process is effective upon receipt of a complete notification by the Anti-Doping Organization. Incomplete notifications must be returned to the applicant; (b) on receipt of a complete notification, the Anti-Doping Organization shall promptly advise the Athlete. As appropriate, the Athlete’s IF, NF and NADO shall also be advised. The Anti-Doping Organization shall advise WADA only upon receipt of a notification from an International-level Athlete; (c) a notification for an ATUE will not be considered for retroactive approval except: – if emergency treatment or treatment of an acute medical condition was necessary; or – due to exceptional circumstances, there was insufficient time or opportunity for an applicant to submit, or a TUEC to receive, an application prior to Doping Control. 8.5 (a) A review by the TUEC or the WADA TUEC can be initiated at any time during the duration of an ATUE. (b) If an Athlete requests a review of a subsequent denial of an ATUE, the WADA TUEC will have the ability to request from the Athlete additional medical information as deemed necessary, the expenses of which should be met by the Athlete. 8.6 An ATUE may be cancelled by the TUEC or WADA TUEC at any time. The Athlete, his/her IF and all relevant Anti-Doping Organizations shall be notified immediately. 8.7 The cancellation shall take effect immediately following notification of the decision to the Athlete. The Athlete will nevertheless be able to apply under section 7 for a TUE. 9.0 Clearing house 9.1 Anti-Doping Organizations are required to provide WADA with all TUEs, and all supporting documentation, issued under section 7. 9.2 With respect to ATUEs, Anti-Doping Organizations shall provide WADA with medical applications submitted by International-level Athletes issued under section 8.4 9.3 The Clearing house shall guarantee strict confidentiality of all the medical information. 2007/56. szám A SPORTBELI DOPPING ELLENI NEMZETKÖZI EGYEZMÉNY Preambulum Az Egye sült Nem ze tek Ne ve lés ügyi, Tu do má nyos és Kul tu rá lis Szer ve ze te, a továb biak ban: UNESCO, Köz - gyû lé se a 2005. ok tó ber 3–21-én meg tar tott 33. ülé sén te kin tet be véve az UNESCO azon cél ját, hogy a nem ze - tek nek a ne ve lés, a tu do mány és a kul tú ra te rén való együtt mû kö dé sé nek elõ se gí té se ré vén hoz zá já rul jon a béke és biz ton ság meg te rem té sé hez, hi vat koz ván az em be ri jo gok kal kap cso la tos nem zet kö - zi do ku men tu mok ra, an nak tu da tá ban, hogy az ENSZ Köz gyû lés 2003. no - vem ber 3-án el fo gad ta az 58/5. sz. Ha tá ro za tot, kü lö nö sen an nak 7. cik két, mi sze rint a sport az ok ta tás, az egész ség, a fej lõ dés és a béke elõ se gí tés nek az esz kö ze, an nak tu da tá ban, hogy a sport nak fon tos sze re pet kell ját sza ni az egész ség vé del mé ben, az er köl csi, kul tu rá lis és tes ti ne ve lés ben, va la mint a nem zet kö zi béke és meg ér tés elõ se gí té sé ben, meg ál la pít va a dop ping fel szá mo lá sát cél zó nem zet kö zi együtt mû kö dés bá to rí tá sá nak és össze han go lá sá nak a szük sé ges sé gét, ag go da lom mal te kint ve a dop ping nak a spor to lók kö ré - ben való al kal ma zá sá ra, és en nek az egész sé gük re, a sport - sze rû ség re, a csa lás ki zá rá sá ra és a sport jö võ jé re gya ko - rolt kö vet kez mé nye i re, an nak tu da tá ban, hogy a dop ping ve szé lyez te ti az UNES CO-nak a Test ne ve lés és a Sport Nem zet kö zi Char - tá já ban, va la mint Olim pi ai Char tá ban meg tes te sült eti kai el ve ket és ne ve lé si ér té ke ket, em lé kez tet ve, hogy az Eu ró pa Ta nács ke re té ben el fo ga - dott Dop ping el le nes Egyez mény és an nak Ki egé szí tõ Jegy zõ köny ve je len tik azo kat a nem zet kö zi jogi esz kö zö - ket, ame lyek a nem ze ti dop ping el le nes po li ti kák és az e té - ren meg va ló su ló nem zet kö zi együtt mû kö dés ki in du ló - pont ját je len tik, em lé kez tet ve az UNESCO Test ne ve lé sért és Spor tért Fe le lõs Mi nisz te rek és Ve ze tõ Tiszt ség vi se lõk Moszk vá - ban (1988), Pun ta del Es te-ben (1999) és A thén ban (2004) tar tott 1., 2. és 3. nem zet kö zi kon fe ren ci á ján a dop ping gal kap cso lat ban el fo ga dott aján lá sa i ra, va la mint az UNESCO Köz gyû lé se 32. ülé sén (2003) el fo ga dott 32 C/9. sz. Ha tá - ro za tá ra, szem elõtt tart va a Nem zet kö zi Dop ping el le nes Ügy - nök ség ál tal a 2003. már ci us 5-én Kop pen há gá ban a Dop - ping Világ kongresszuson el fo ga dott Nem zet kö zi Dop - ping el le nes Sza bály za tot, va la mint a Kop pen há gá ban el - fo ga dott Dop ping el le nes Nyi lat ko za tot, to váb bá an nak tu da tá ban, hogy mi lyen ha tást gya ko rol - nak az él spor to lók az if jú ság ra, an nak tu da tá ban, hogy foly tat ni kell, és elõ kell se gí te ni a dop ping hasz ná lat ki mu ta tá sát ja ví tó ku ta tá so kat, va la - mint azo két, ame lyek a dop ping hasz ná lat té nye zõ i nek jobb meg ér té sét szol gál ják az zal a cél lal, hogy a meg elõ - zést szol gá ló stra té gi ák ha té ko nyab bak le hes se nek, tu da tá ban léve, hogy a spor to lók, a spor to lók kal fog lal - ko zó sze mély zet, és ál ta lá ban a kö zös ség fo lya ma tos ne ve - lé sé nek fon tos sze re pe van dop ping hasz ná lat meg elõ zé sé - ben, szem elõtt tart va an nak szük sé ges sé gét, hogy se gít sük a Ré szes Ál la mo kat a dop ping el le nes prog ra mok al kal ma - zá sá ban, an nak tu da tá ban, hogy a spor tért fe le lõs ha tó sá gok nak és szer ve ze tek nek pót ló la gos fe le lõs sé ge a dop ping hasz - ná lat meg aka dá lyo zá sa és az el le ne foly ta tott harc, ne ve - ze te sen a sport ese mé nyek nek a sport sze rû ség el ve i vel össz hang ban való meg ren de zé sé nek biz to sí tá sa, és az azo - kon részt ve võk egész sé gé nek a vé del me, fel is mer ve, hogy a ha tó sá gok nak és a szer ve ze tek nek a leg ma ga sabb fokú füg get len ség és át lát ha tó ság biz to sí tá sa mel lett min den meg fe le lõ szin ten együtt kell dol goz ni uk ezen cé lok meg va ló sí tá sá ért, az zal a szán dék kal, hogy a dop ping hasz ná lat meg szün - te té sét cél zó to váb bi és szi lár dabb együtt mû kö dés tör tén - jék, fel is mer ve, hogy a dop ping hasz ná lat meg szün te té se rész ben a dop ping el le nes el vek és gya kor lat ha tá sos har - mo ni zá ci ó já tól, va la mint a nem ze ti és nem zet kö zi szin ten meg va ló su ló együtt mû kö dés tõl függ, a mai na pon, 2005. ok tó ber 19-én el fo gad ja az aláb bi Egyez ményt: I. Rész HATÁLYOSSÁG

Source: https://magyarkozlony.hu/hivatalos-lapok/46f6c6a1ded80d2e43f529a4cf8ff72403f2abf4/dokumentumok/32e8875d26273f922b8b5ce8d3049e0929b015a8/letoltes